Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 14.15
-0.17 (-1.19%)
Aug 21, 2026, 9:30 AM EST
Cipher Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 49.62 | 50.45 | 33.36 | 21.16 | 20.68 | 21.94 | |
Revenue Growth | 4.27% | 51.22% | 57.66% | 2.36% | -5.78% | 1.55% |
Cost of Revenue | 9.23 | 10.03 | 9.26 | 4.07 | 3.99 | 3.68 |
Gross Profit | 40.4 | 40.42 | 24.1 | 17.09 | 16.68 | 18.26 |
Selling, General & Admin | 13.47 | 16.3 | 12.24 | 5.43 | 4.55 | 5.11 |
Research & Development | - | 0.02 | - | 0.14 | 0.1 | 0.09 |
Operating Expenses | 20.67 | 23.56 | 16.26 | 6.79 | 5.63 | 5.2 |
Operating Income | 19.73 | 16.87 | 7.85 | 10.3 | 11.05 | 13.06 |
Interest Expense | -0.39 | -1.17 | - | - | - | -0.08 |
Interest & Investment Income | - | - | 0.33 | 1.87 | 0.46 | - |
Currency Exchange Gain (Loss) | -1.58 | 1.69 | -2.51 | 0.78 | -0.04 | 0.08 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 0.01 |
EBT Excluding Unusual Items | 17.76 | 17.39 | 5.67 | 12.95 | 11.48 | 13.07 |
Merger & Restructuring Charges | -0.48 | -0.35 | -2.72 | -0.27 | - | - |
Gain (Loss) on Sale of Assets | 0.19 | 0.13 | - | - | - | -0.76 |
Legal Settlements | - | - | - | - | - | -1.25 |
Pretax Income | 17.46 | 17.16 | 2.96 | 12.68 | 11.48 | 11.06 |
Income Tax Expense | -11.52 | -10.17 | -8.59 | -7.7 | -15.16 | 3.3 |
Earnings From Continuing Operations | 28.99 | 27.33 | 11.55 | 20.38 | 26.64 | 7.76 |
Net Income | 28.99 | 27.33 | 11.55 | 20.38 | 26.64 | 7.76 |
Net Income to Common | 28.99 | 27.33 | 11.55 | 20.38 | 26.64 | 7.76 |
Net Income Growth | 138.70% | 136.72% | -43.36% | -23.48% | 243.34% | 70.54% |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 | 27 |
Shares Outstanding (Diluted) | 26 | 26 | 25 | 25 | 26 | 27 |
Shares Change | -1.02% | 3.04% | -0.79% | -1.46% | -3.84% | -1.96% |
EPS (Basic) | 1.14 | 1.07 | 0.47 | 0.82 | 1.05 | 0.29 |
EPS (Diluted) | 1.12 | 1.05 | 0.46 | 0.80 | 1.03 | 0.29 |
EPS Growth | 140.95% | 128.26% | -42.50% | -22.33% | 255.17% | 74.74% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 27.02 | 29.7 | -60.5 | 15.86 | 10.64 | 13.81 |
Free Cash Flow Per Share | 1.05 | 1.14 | -2.40 | 0.62 | 0.41 | 0.52 |
Gross Margin | 81.40% | 80.12% | 72.25% | 80.77% | 80.69% | 83.21% |
Operating Margin | 39.76% | 33.43% | 23.52% | 48.68% | 53.45% | 59.51% |
Profit Margin | 58.42% | 54.17% | 34.60% | 96.32% | 128.83% | 35.35% |
Free Cash Flow Margin | 54.44% | 58.87% | -181.33% | 74.92% | 51.48% | 62.95% |
EBITDA | 26.48 | 23.81 | 11.69 | 11.44 | 11.95 | 13.66 |
EBITDA Margin | 53.36% | 47.20% | 35.04% | 54.06% | 57.80% | 62.25% |
D&A For EBITDA | 6.75 | 6.95 | 3.84 | 1.14 | 0.9 | 0.6 |
EBIT | 19.73 | 16.87 | 7.85 | 10.3 | 11.05 | 13.06 |
EBIT Margin | 39.76% | 33.43% | 23.52% | 48.68% | 53.45% | 59.51% |
Effective Tax Rate | - | - | - | - | - | 29.85% |
Revenue as Reported | 49.62 | 50.45 | 33.36 | 21.16 | 20.68 | 21.94 |